GGrantIndex
Sort

11,323 grants matching glioblastoma

Biochemical and cell biological mechanisms of signal transduction through the Hedgehog pathway

$2
Rajat Rohatgi · Stanford University · R35 · FY2016 · GM

Comparative Pathology Core

$2
Amy Cleveland Durham · University Of Pennsylvania · P30 · FY2021 · CA

Toward Multi-Center MR Brain Perfusion

$1
Steven Stufflebeam · Massachusetts General Hospital · R01 · FY2014 · NS

AI-powered chemical proteomics for drug discovery targeting orphan proteins

$1
Lei Xie · Hunter College · R01 · FY2025 · GM

Role and Therapeutic Value of AHR in Inflammatory Macrophages during GBM

$1
Francisco J. Quintana · Brigham And Women'S Hospital · R21 · FY2015 · NS

Therapeutically Exploiting a Newly Isolated Neural-Like Stem Cell Against GSB

$1
Akiva Mintz · Columbia University Health Sciences · R01 · FY2017 · CA

Apical-basal polarity signaling in glioblastoma

$1
Sourav Ghosh · University Of Arizona · R01 · FY2014 · CA

Targeting Refractory EGFR-Driven Tumors By Induction Of Dominant-Negative EGFR Splicing Variants

$1
Luca Cartegni · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA

Optimizing CAR T therapy via metabolic engineering for thetreatment of GBM

$1
Loic Pierre Deleyrolle · University Of Florida · R21 · FY2024 · CA

Defining the role of BRAF in glioma initiation and maintenance

$1
Sheri L. Holmen · Nevada Cancer Institute · R01 · FY2011 · NS

Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma

$1
Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

High-throughput Optimization of Polymeric Nanoparticles for Small RNA Delivery to Treat Glioblastoma

$1
Yuan Rui · Johns Hopkins University · F31 · FY2021 · CA

Molecular Oncogenic Properties of Mutant p53

$1
Xinbin Chen · University Of Alabama At Birmingham · R01 · FY2007 · CA

Advanced prediction of GBM recurrence (TIME) for personalized radiotherapy

$1
Wensha Yang · University Of Southern California · R21 · FY2022 · CA

Informatics Platform for Mammalian Gene Regulation at Isoform-level

$1
Ramana V Davuluri · Northwestern University At Chicago · R01 · FY2020 · LM

Methylation and mutations in RB1 and variants of synthetic folic acid metabolism

$1
Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2017 · CA

Comparative Pathology Core

$1
Douglas J Epstein · University Of Pennsylvania · P30 · FY2023 · CA

A phase Ib/II study of AZD2171 and radiation for new brain metastases from NSCLC

$1
April Fitzsimmons Eichler · Massachusetts General Hospital · R21 · FY2010 · CA

Metabolic reprogramming to improve EGFRvIII CAR T cell persistence

$1
John H Sampson · Duke University · R21 · FY2022 · CA

Translational Development of Replication-Competent Retrovirus Vectors

$1
Noriyuki Kasahara · University Of California Los Angeles · U01 · FY2013 · NS

Imaging-based tumor forecasting to predict brain tumor progression and response to therapy

$1
Christopher Chad Quarles · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Mechanisms of Biguanide Sensitivity in GBM

$1
Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · NS

Pre-clinical evaluation of Magnetically labeled Cells for Cellular MRI

$0
Joseph Frank · Clinical Center · ZIA · FY2015 · CL

Pre-clinical evaluation of Magnetically labeled Cells for Cellular MRI

$0
Joseph Frank · Clinical Center · ZIA · FY2017 · CL

Pre-clinical evaluation of Magnetically labeled Cells for Cellular MRI

$0
Joseph Frank · Clinical Center · ZIA · FY2014 · CL